http://www.bbbiotech.ch/ NAV BB Biotech en http://www.bbbiotech.ch/fileadmin/img/rss.gif http://www.bbbiotech.ch/ 49 22 NAV BB Biotech http://backend.userland.com/rss091 Tue, 08 Dec 2009 08:51:00 +0100 http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-november-2009/ - Incyte: Announcement of a major partnership with Novartis- BioXell: Support of the planned... http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-october-2009/ - Vertex announces impressive Telaprevir data at the AASLD Meeting- Actelion reports solid 9-months... http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-september-2009/ - BB BIOTECH: Initiation of 6th share buyback on September 16, 2009- Incyte: Positive Phase II... http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-august-2009/ Actelion receives Tracleer label extension and approval for new Ventavis formulation in the... http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-july-2009-1/ - Celgene: Clinical study for use of Revlimid as a first-line treatment of multiple myeloma stopped... http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-june-2009-1/ - ASCO meeting highlights- Arena: presentation of Lorcaserin data at ADA http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-may-2009-1/ - Roche: Important new treatment option approved in the US for patients with the most aggressive... http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-april-2009-1/ - Actelion reported strong revenues and earnings - important news from clinical development... http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-march-2009-1/ -Roche and Genentech reach a friendly agreement to combine the two organizations-Celgene expects... http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/presentation-star-conference-milano-as-of-march-252009/ http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-february-2009/ - Genentech's special committee rejects Roche's tender offer- Actelion: Actelion 2008 Financial... http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-january-2009/ - Roche announces tender offer for Genentech shares- ZymoGenetics and Bristol-Myers Squibb enter... http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/corporate-presentation-february-2009-1/ http://www.bbbiotech.ch/en/bb-biotech/investor-relations/latest-info/detail/article/monthly-news-december-2008-1/ - Actelion: Zavesca receives positive opinion for treating Niemann-Pick type C disease- NicOx: The...